ZimVie (NASDAQ:ZIMV – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 0.550-0.700 for the period, compared to the consensus EPS estimate of 0.590. The company issued revenue guidance of $450.0 million-$460.0 million, compared to the consensus revenue estimate of $453.9 million.
ZimVie Stock Performance
NASDAQ:ZIMV traded down $3.10 during midday trading on Friday, hitting $17.30. The company’s stock had a trading volume of 1,723,003 shares, compared to its average volume of 426,869. ZimVie has a fifty-two week low of $6.52 and a fifty-two week high of $22.40. The firm’s 50 day moving average is $18.05 and its 200-day moving average is $17.54. The company has a debt-to-equity ratio of 1.32, a current ratio of 2.68 and a quick ratio of 2.23. The firm has a market cap of $472.12 million, a P/E ratio of -1.24 and a beta of 2.18.
ZimVie (NASDAQ:ZIMV – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported $0.13 earnings per share for the quarter. The company had revenue of $116.81 million for the quarter. ZimVie had a negative net margin of 63.84% and a positive return on equity of 2.09%. During the same quarter last year, the company posted $0.17 EPS. Equities analysts anticipate that ZimVie will post 0.63 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
View Our Latest Research Report on ZIMV
About ZimVie
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Articles
- Five stocks we like better than ZimVie
- What Does Downgrade Mean in Investing?
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- There Are Different Types of Stock To Invest In
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Most active stocks: Dollar volume vs share volume
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.